Table 2. Antioxidant activity of PBPs and different formulations of nanoliposomes
Sample | Nanoliposome | EC50 (ppm) |
DPPH | ABTS |
PBPs | − | 234.5 ± 6.95b | 317.13 ± 7.46b |
F1 | 0% CH | 268.33 ± 17.12a | 362.87 ± 5.80a |
F2 | 0.5% CH | 227.6 ± 6.77b | 320.63 ± 6.80b |
F3 | 1% CH | 193.63 ± 2.63c | 239.37 ± 11.81c |
F4 | 1.5% CH | 81.27 ± 1.40d | 107.67 ± 6.76d |
BHT | − | 34.20 ± 3.60e | 87.47 ± 2.40e |
Ascorbic acid | − | 79.20 ± 0.90d | 108.03 ± 3.42d |
Values are mean ± SD of three determinations.
Small letters presented differences between treatments in each column.
DPPH, 1,1-diphenyl-2-picrylhydrazyl; ABTS, 2,2-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid; PBPs, phycobiliproteins; F1, uncoated nanoliposomes; F2, nanoliposomes coated with 0.5% CH; F3, nanoliposomes coated with 1% CH; F4, nanoliposomes coated with 1.5% CH; BHT, butylated hydroxytoluene.